Moberg Pharma AB | |
Stock Exchange | OTC Publication Venue |
EPS |
SEK1.49 |
Market Cap |
SEK1.17 B |
Shares Outstanding |
17.7 M |
Public Float |
14.33 M |
Address |
Gustavslundsvägen 42, 5 tr Bromma AB 167 51 Sweden |
Employees | - |
Website | http://www.mobergpharma.se |
Updated | 07/08/2019 |
Moberg Pharma AB is a pharmaceutical company, which engages in the development and commercialization of medical products. It offers its products through the following brands: Kerasal, Kerasal Nail, Balmex, NewSkin, Dermoplast, Domeboro, and Fiber Choice. The company was founded by Peter Gunnar Maurits Wolpert and Marie Moberg in March 2006 and is headquartered in Bromma, Sweden. |